Floatz logo

40 assets in IDH-Wildtype Glioblastoma

Therapeutic assets addressing IDH-Wildtype Glioblastoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
IDH-Wildtype Glioblastoma
National Cancer Institute (NCI)P2B (58)
Ipilimumab
IDH-Wildtype Glioblastoma
Neonc Technologies, Inc.P2B (58)
Nivolumab
IDH-Wildtype Glioblastoma
Neonc Technologies, Inc.P2B (58)
Pembrolizumab
IDH-Wildtype Glioblastoma
Mayo ClinicP2B (58)
Cerebraca Wafer
IDH-Wildtype Glioblastoma
Everfront Biotech Co., Ltd.P2/3B (57)
Lomustine
IDH-Wildtype Glioblastoma
Vastra Gotaland RegionP3B (56)
Adriamycin
IDH-Wildtype Glioblastoma
Northwestern UniversityP2CCC (53)
Atezolizumab
IDH-Wildtype Glioblastoma
National Cancer Institute (NCI)P2CCC (53)
Atorvastatin
IDH-Wildtype Glioblastoma
Tianjin Medical University General HospitalP2CCC (53)
AXUMIN
IDH-Wildtype Glioblastoma
ECOG-ACRIN Cancer Research GroupP2CCC (53)
Balstilimab
IDH-Wildtype Glioblastoma
Northwestern UniversityP2CCC (53)
Botensilimab
IDH-Wildtype Glioblastoma
Northwestern UniversityP2CCC (53)
gi-102
IDH-Wildtype Glioblastoma
Mayo ClinicP2CCC (53)
Metformin
IDH-Wildtype Glioblastoma
Hopital FochP2CCC (53)
Regorafenib
IDH-Wildtype Glioblastoma
Neonc Technologies, Inc.P1/2CCC (53)
Tiragolumab
IDH-Wildtype Glioblastoma
National Cancer Institute (NCI)P2CCC (53)
WP 1066
IDH-Wildtype Glioblastoma
Northwestern UniversityP2CCC (53)
Elemene
IDH-Wildtype Glioblastoma
Peking Union Medical College HospitalP2CCC (51)
Eflornithine
IDH-Wildtype Glioblastoma
Mayo ClinicP1/2CCC (50)
Efineptakin Alfa
IDH-Wildtype Glioblastoma
Mayo ClinicP2CCC (49)
LMP744
IDH-Wildtype Glioblastoma
National Institute of Neurological Disorders and Stroke (NINDS)P1/2CC (47)
p134 cell
IDH-Wildtype Glioblastoma
Tasly Pharmaceutical Group Co., LtdP1/2CC (47)
Ropidoxuridine
IDH-Wildtype Glioblastoma
Shuttle Pharmaceuticals, Inc.P2CC (47)
Selinexor
IDH-Wildtype Glioblastoma
National Cancer Institute (NCI)P1/2CC (47)
Carboplatin
IDH-Wildtype Glioblastoma
Neonc Technologies, Inc.P1/2CC (45)
neo212
IDH-Wildtype Glioblastoma
Neonc Technologies, Inc.P1/2CC (45)
Retifanlimab
IDH-Wildtype Glioblastoma
Mayo ClinicP1/2CC (45)
2141 v11
IDH-Wildtype Glioblastoma
Darell BignerP1CC (43)
Allogeneic Adipose-Derived Mesenchymal Stem Cells
IDH-Wildtype Glioblastoma
Mayo ClinicP1CC (43)
Anti-Il13Ralpha2 Car T-Cells
IDH-Wildtype Glioblastoma
City of Hope Medical CenterP1CC (43)
d2c7-it
IDH-Wildtype Glioblastoma
Darell BignerP1CC (43)
Eras-801
IDH-Wildtype Glioblastoma
Jonsson Comprehensive Cancer CenterP1CC (43)
Fludeoxyglucose
IDH-Wildtype Glioblastoma
Jonsson Comprehensive Cancer CenterP1CC (43)
Oncolytic Adenovirus Ad5-Dnx-2401
IDH-Wildtype Glioblastoma
M.D. Anderson Cancer CenterP1CC (43)
Triapine
IDH-Wildtype Glioblastoma
National Cancer Institute (NCI)P1CC (43)
Debio 0123
IDH-Wildtype Glioblastoma
Debiopharm International SAP1/2CC (42)
Vipivotide Tetraxetan
IDH-Wildtype Glioblastoma
Memorial Sloan Kettering Cancer CenterP1CC (41)
[177lu]lu-dota-eb-rgd2
IDH-Wildtype Glioblastoma
Beijing Tiantan HospitalEarly P1C (39)
[177lu]lu-xt771
IDH-Wildtype Glioblastoma
Beijing Tiantan HospitalEarly P1C (39)
wsd0922-fu
IDH-Wildtype Glioblastoma
Mayo ClinicP1C (39)